This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tobias, J. D. Articles by Grindstaff, R. Search for Related Content PubMed PubMed Citation Articles by Tobias, J. D. Articles by Grindstaff, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB MIDAZOLAM HYDROCHLORIDE PROPOFOL Social Bookmarking                   What's this?

Bispectral Index Monitoring During the Administration of Neuromuscular Blocking Agents in the Pediatric Intensive Care Unit Patient

Departments of Pediatrics and Anesthesiology, University of Missouri, Columbia, MO, Tobiasj{at}health.missouri.edu

Ryan Grindstaff, MD, PhD

University of Missouri School of Medicine, Columbia, MO

Bispectral index (BIS) values were prospectively recorded in pediatric intensive care unit patients receiving continuous infusion of a neuromuscular blocking agent. Sedation was provided by a continuous infusion of midazolam or propofol. The BIS number was recorded by a bedside computer every 10 seconds but was concealed from health care workers. BIS values were recorded for 476 hours (161 893 BIS values) in 12 patients. The BIS number was 50 to 70, 57% of the time; 49, 35% of the time; and 71, 8% of the time. When supplemental doses of sedatives were administered, the BIS number was >70, 64% of the time; 50 to 70, 31% of the time; and 49, 5% of the time. Oversedation was more likely with propofol than midazolam. During the use of neuromuscular blocking agents, oversedation is a common occurrence. Physiologic parameters are not an accurate means of assessing the depth of sedation.

Key Words: bispectral index • propofol • midazolam • neuromuscular blocking agents

Journal of Intensive Care Medicine, Vol. 20, No. 4, 233-237 (2005)
DOI: 10.1177/0885066605276806


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?